November 25, 2025

Reprogramming the Immune System: Cancer Vaccines, Collaboration, and Communication

From the University of Houston to MD Anderson Cancer Center, Cole Woody’s journey shows how curiosity and collaboration can drive major discoveries. He reflects on the promise of repurposed mRNA vaccines, the technical art of immunology, and the social side of science.

The Medicine Maker

November 24, 2025

Access to Advanced Therapies Hinges on AI and Collaboration

AI and collaboration can transform cell and gene therapy by integrating data, improving manufacturing handoffs, and enabling personalized, scalable treatments.

The Medicine Maker

November 20, 2025

Bringing New Ideas to AAV Gene Therapy

As safety concerns and commercial doubts threaten the AAV gene therapy field, new technologies may offer a “well-rounded” solution.

The Medicine Maker

November 18, 2025

‘Designed to Scare People’? New Contraception Data

Hormonal contraception shows overall safety with a modest, short-term rise in breast cancer risk.

KFF Health News

November 18, 2025

PPIs Linked to Worse Breast Cancer Outcomes

Pooled analysis of nearly 23,000 patients shows medication commonly used for acid reflux may interfere with cancer treatment effectiveness.

Conexiant

November 13, 2025

The Analytical Scientist Innovation Awards 2025: #1

The technology ranked first in our 2025 Innovation Awards is… Countable PCR, from Countable Labs

The Analytical Scientist

November 11, 2025

Routine AI Assistance May Lead to Loss of Skills in Endoscopists, Study Shows

Budzyń et al.'s study raises concerns over the negative impact of AI on endoscopist skills in colonoscopy detection—an essential task in preventing colon cancer.

The ASCO Post

November 11, 2025

Model for Predicting Risk of Heart Failure or Cardiomyopathy After Breast Cancer Treatment

In a study reported in JAMA Oncology, Barac et al developed a risk prediction model for heart failure or cardiomyopathy after breast cancer treatment.

The ASCO Post

November 11, 2025

Could AI Unlock Mass Spectrometry’s Full Discovery Potential?

Self-supervised learning models – such as Matterwork’s Large Spectral Model – turn raw spectra into biological insight in minutes

The Analytical Scientist